Skanda Lifesciences Private Limited, a active private limited company, was established on 13 November 2012 in Bangalore, Karnataka, India. Engaging in accounting and financial analysis within the professional, scientific and technical sector, it holds CIN: U73100KA2012PTC066675. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 28 professional, Its leadership includes Swathi Shetty (Director), Shivnna Yogisha (Director). It holds ₹1.29 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy No. 47, No.10, 11 & 12, Shree Shyla Bramara, Chandana Layout, Srigandhada Kaval, Naga, Rbhavi,, Bangalore, Karnataka, 560091.
U73100KA2012PTC066675
066675
13 November 2012
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Skanda Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swathi Shetty | Director | 13 Nov 2012 | Current |
| Shivnna Yogisha | Director | 13 Nov 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skanda Lifesciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 38.9% increase. The company also saw a substantial improvement in profitability, with a 14.14% increase in profit. The company's net worth Soared by an impressive increase of 44.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Skanda Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,850,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2023 | State Bank Of India | ₹2.65 M | Open |
| 31 Jan 2020 | State Bank Of India | ₹6.00 M | Open |
| 12 Dec 2018 | Others | ₹2.70 M | Open |
| 05 Apr 2013 | Bank Of Baroda | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Skanda Lifesciences has a workforce of 28 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skanda Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skanda Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Skanda Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Skanda Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
A charge with State Bank Of India amounted to Rs. 2.65 M with Charge ID 100691426 was registered on 07 Mar 2023. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 6.00 M with Charge ID 100325967 was registered on 31 Jan 2020. was documented.
The activity A charge with Others amounted to Rs. 2.70 M with Charge ID 100225081 was registered on 12 Dec 2018. was completed.
The activity A charge with Bank Of Baroda amounted to Rs. 1.50 M with Charge ID 10423998 was registered on 05 Apr 2013. was completed.
The CIN of Skanda Lifesciences Private Limited is U73100KA2012PTC066675.
Skanda Lifesciences Private Limited is headquartered at Sy No. 47, No.10, 11 & 12, Shree Shyla Bramara, Chandana Layout, Srigandhada Kaval, Naga, Rbhavi,, Bangalore, Karnataka, 560091.
Skanda Lifesciences Private Limited was incorporated on 13 November 2012.
The current directors of Skanda Lifesciences Private Limited are
The primary industry of Skanda Lifesciences Private Limited is Professional, Scientific And Technical.
Skanda Lifesciences Private Limited is unlisted.
The authorized capital of Skanda Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Skanda Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX